Citation Impact
Citing Papers
The management of acute otitis media
1984
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
Immunosenescence and human vaccine immune responses
2019
Activating a collaborative innate-adaptive immune response to control metastasis
2021
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Rheumatoid arthritis
2018 Standout
A guide to vaccinology: from basic principles to new developments
2020
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Sexual dimorphism of humoral immunity with human vaccines
2008
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live
2019
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
2018
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
2020
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
2011
Tissue-resident macrophages
2013 Standout
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
2016
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The Xs and Y of immune responses to viral vaccines
2010
Emerging concepts in the science of vaccine adjuvants
2021
The emerging safety profile of JAK inhibitors in rheumatic disease
2017
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Vaccines for preventing influenza in healthy adults
2010
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Varicella zoster virus infection
2015
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
2011
Sex differences in immune responses
2016 Standout
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
2013
Risk of gout flares after vaccination: a prospective case cross-over study
2019
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Systematic review of incidence and complications of herpes zoster: towards a global perspective
2014 Standout
From discovery to licensure, the Adjuvant System story
2016
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1996
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
2017
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses
2017
Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
2018
Vaccines for preventing influenza in healthy adults
2014
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Immune correlates of vaccine protection against HIV-1 acquisition
2015
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
2018 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
Gout
2021 Standout
Understanding modern-day vaccines: what you need to know
2017
Surveillance of Vaccination Coverage among Adult Populations — United States, 2015
2017
Vaccines for preventing influenza in the elderly
2018
Post-herpetic neuralgia
2016
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
2019
Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
2019 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
2017
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
2016
Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
2019
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Industry sponsorship and research outcome
2017 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
New Gram-negative enteropathogens: fact or fancy?
2006
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
2022 StandoutNobel
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Roman Chlíbek being referenced
Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
2015
Diarrhea Outbreak among Czech Army Field Hospital Personnel Caused by Providencia alcalifaciens
2006
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials
2009
Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
2014
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Hepatitis A/B vaccination of adults over 40 years old: Comparison of three vaccine regimens and effect of influencing factors
2006
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines
2008
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
2013
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial
2019
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
2018
[Effectiveness of influenza vaccination in healthy adults--a fourfold decrease in influenza morbidity during one influenza season].
2002